These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7541057)

  • 1. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.
    Droogan AG; McMillan SA; Douglas JP; Hawkins SA
    J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jan; 56(1):113-6. PubMed ID: 7822477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
    Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
    Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
    J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
    Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy.
    Tsujino A; Nakamura T; Furuya T; Goto H; Nishiura Y; Shirabe S; Nakane S; Motomura M; Nagataki S
    J Neurol Sci; 1998 Feb; 155(1):76-9. PubMed ID: 9562326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
    Ann Neurol; 1993 Jun; 33(6):646-9. PubMed ID: 8098933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K
    Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
    Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
    Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.
    McDonnell GV; McMillan SA; Douglas JP; Droogan AG; Hawkins SA
    J Neuroimmunol; 1998 May; 85(2):186-92. PubMed ID: 9630167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble adhesion molecules in ANCA-associated vasculitis.
    Ara J; Mirapeix E; Arrizabalaga P; Rodriguez R; Ascaso C; Abellana R; Font J; Darnell A
    Nephrol Dial Transplant; 2001 Feb; 16(2):276-85. PubMed ID: 11158400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble NCAM in multiple sclerosis.
    Ziliotto N; Zivadinov R; Jakimovski D; Baroni M; Tisato V; Secchiero P; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Bernardi F; Ramanathan M; Marchetti G
    J Neurol Sci; 2019 Jan; 396():36-41. PubMed ID: 30412901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.
    Hayashi D; Kubota R; Takenouchi N; Nakamura T; Umehara F; Arimura K; Izumo S; Osame M
    J Neurovirol; 2008 Oct; 14(5):459-63. PubMed ID: 18989817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    Neurology; 1993 Dec; 43(12):2679-82. PubMed ID: 8255476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.